Navigation
Navigation
User login
Back to top

Publications

Search the full list of publications from EUMDS.

Search

Results of the EUMDS Registry will be published in scientific articles and presented on haematological conferences, like ASH, EHA, ESH, MDS-Foundation and European LeukemiaNet meetings. Main results are summarized on the Lay summaries page.

Displaying 147 results from 147 total publications.

van Zeventer et al. 2022.

Evolutionary landscape of clonal hematopoiesis revealed by longitudinal error-corrected sequencing in 3359 older community-based individuals

Isabelle A. van Zeventer,  Aniek O. De Graaf,  Jonas B. Salzbrunn,  Nolte, I,  Kamphuis, P,  Dinmohamed, AG,  Bert A. van der Reijden,  Jan Jacob Schuringa,  JH Jansen,  Gerwin Huls.

EHA Library
Volume: 366211; LB2368.

Garelius et al. 2022.

Erythropoietin stimulation agents significantly improves outcome in lower risk MDS

H Garelius,  Alexandra Smith,  Tim Bagguley,  Adele Taylor,  Pierre Fenaux,  David Bowen,  Argiris Symeonidis,  Moshe Mittelmann,  R Stauder,  Jaroslav Cermak,  Guillermo Sanz,  Saskia Langemeijer,  Luca Malcovati,  Ulrich Germing,  Raphael Itzykson,  A Guerci-Bresler,  Dominic Culligan,  Ioannis Kotsianidis,  K. Koinig,  C. Van Marrewijk,  Simon Crouch,  T de Witte,   Hellstrom-Lindberg.

HemaSphere
Volume: 6, Issue: S168, Pages: 69-70.

van Zeventer et al. 2022.

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

Isabelle A. van Zeventer,  Aniek O. de Graaf,  Theresia N Koorenhof-Scheele,  Bert A. van der Reijden,  Melanie van der Klauw,  Avinash G Dinmohamed,  Arjan Diepstra,  Jan Jacob Schuringa,  Luca Malcovati,  Gerwin Huls,  Joop H Jansen.

Blood Advances
Pages: bloodadvances.2021006755.

Bachas et al. 2022.

Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry

Costa Bachas,  Carolien Duetz,  Margot F. van Spronsen,  Jan Verhoeff,  Juan J. Garcia Vallejo,  Joop H. Jansen,  Jacqueline Cloos,  Theresia M. Westers,  Arjan A. van de Loosdrecht.

Cytometry Part B: Clinical Cytometry
Pages: cyto.b.22066.

Lafage-Pochitaloff et al. 2022.

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11

Marina Lafage-Pochitaloff,  Bastien Gerby,  Véronique Baccini,  Laetitia Largeaud,  Vincent Fregona,  Naïs Prade,  Pierre-Yves Juvin,  Laura Jamrog,  Pierre Bories,  Sylvie Hébrard,  Stéphanie Lagarde,  Véronique Mansat-De Mas,  Oliver M. Dovey,  Kosuke Yusa,  George S. Vassiliou,  Joop H. Jansen,  Tobias Tekath,  David Rombaut,  Geneviève Ameye,  Carole Barin,  Audrey Bidet,  John Boudjarane,  Marie-Agnès Collonge-Rame,  Carine Gervais,  Antoine Ittel,  Christine Lefebvre,  Isabelle Luquet,  Lucienne Michaux,  Nathalie Nadal,  Hélène A. Poirel,  Isabelle Radford-Weiss,  Bénédicte Ribourtout,  Steven Richebourg,  Stéphanie Struski,  Christine Terré,  Isabelle Tigaud,  Dominique Penther,  Virginie Eclache,  Michaela Fontenay,  Cyril Broccardo,  , Eric Delabesse,  Groupe Français des Myélodysplasies, and Groupe Francophone d’Hématologie Cellulaire on behalf of Groupe Francophone de Cytogénétique Hématologique.

Blood Advances
Volume: 6, Issue: 2, Pages: 386-398.

Stojkov et al. 2021.

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A. Koinig,  Marjan Arvandi,  Sibylle Puntscher,  Corine van Marrewijk,  Pierre Fenaux,  Argiris Symeonidis,  Fatiha Chermat,  Hege Garelius,  David Bowen,  Moshe Mittelman,  Elvira Mora,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

Blood Advances
Volume: 6, Issue: 1, Pages: 1-12.

Velden et al. 2021.

Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues—Recommendations from the European <span style="font-variant:small-caps;">LeukemiaNet</span>

Vincent H. J. Velden,  Frank Preijers,  Ulrika Johansson,  Theresia M. Westers,  Alan Dunlop,  Anna Porwit,  Marie C. Béné,  Peter Valent,  Jeroen Marvelde,  Orianne Wagner-Ballon,  Uta Oelschlaegel,  Leonie Saft,  Sharham Kordasti,  Robin Ireland,  Eline Cremers,  Canan Alhan,  Carolien Duetz,  Willemijn Hobo,  Nicolas Chapuis,  Michaela Fontenay,  Peter Bettelheim,  Lisa Eidenshink-Brodersen,  Patricia Font,  Michael R. Loken,  Sergio Matarraz,  Kiyoyuki Ogata,  Alberto Orfao,  Katherina Psarra,  Dolores Subirá,  Denise A. Wells,  Matteo G. Della Porta,  Kate Burbury,  Frauke Bellos,  Elisabeth Weiß,  Wolfgang Kern,  Arjan Loosdrecht.

Cytometry Part B: Clinical Cytometry
Pages: cyto.b.22046.

Wouters et al. 2021.

The anemia-independent impact of myelodysplastic syndromes on health-related quality of life

Hanneke J. C. M. Wouters,  Annette Conrads-Frank,  Karin A. Koinig,  Alex Smith,  Ge Yu,  Theo de Witte,  Bruce H. R. Wolffenbuttel,  Gerwin Huls,  Uwe Siebert,  Reinhard Stauder,  Melanie M. van der Klauw,  on behalf of the MDS-RIGHT partners.

Annals of Hematology
Volume: 100, Issue: 12, Pages: 2921-2932.

T. Silzle et al. 2021.

Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry

T. Silzle,  , A. Taylor,  , T. de Witte,  , L. Malcovati,  , P. Fenaux5,  , D. Bowen,  A. Symeonidis,  R. Stauder,  J. Cermak,  G. Sanz,,  S. Langemeijer,  M. Skov Holm,  A. Savic,  E. Hellström-Lindberg,.

T. Silzle et al. 2021.

Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry

T. Silzle,  , A. Taylor,  , T. de Witte,  , L. Malcovati,  , P. Fenaux5,  , D. Bowen,  A. Symeonidis,  R. Stauder,  J. Cermak,  G. Sanz,,  S. Langemeijer,  M. Skov Holm,  A. Savic,  E. Hellström-Lindberg,.

Swiss Medical Weekly
Volume: 151, Issue: Suppl.255, Pages: P28.

Efficace et al. 2021.

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Fabio Efficace,  Karin A Koinig,  Francesco Cottone,  David Bowen,  Moshe Mittelman,  Saskia M. C. Langemeijer,  Dominic Culligan,  Kalman Filanovsky,  Gregory A. Abel,  Michael Storck,  Alexandra Smith,  Corine Van Marrewijk,  Martin Dugas,  Theo M de Witte,  Reinhard Stauder.

Blood
Volume: 138, Issue: Supplement 1, Pages: 1982.

Bowen et al. 2021.

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

David Bowen,  Adele Taylor,  Pierre Fenaux,  Agnes Guerci-Bresler,  Raphael Itzykson,  Argiris Symeonidis,  Ioannis Kotsianidis,  Moshe Mittelman,  Guillermo Sanz,  Dominic J. Culligan,  Jaroslav Cermak,  Reinhard Stauder,  Eva Hellstrom Lindberg,  Luca Malcovati,  Saskia M. C. Langemeijer,  Ulrich Germing,  Howard S. Oster,  Krzysztof Madry,  Mette Skov Holm,  Alexandra Smith,  Corine van Marrewijk,  Theo M de Witte.

Blood
Volume: 138, Issue: Supplement 1, Pages: 4671.

Silzle T, Taylor A, de Witte T, Malcovati L, Fenaux P, Bowen D, Symeonidis A, Mittelman M, Stauder R, et al. 2021.

Lymphopenia is highly prevalent in MDS and provides additional prognostic information for IPSS-R very-low and low-risk patients. An analyses from the EUMDS Registry.

Silzle T, Taylor A, de Witte T, Malcovati L, Fenaux P, Bowen D, Symeonidis A, Mittelman M, Stauder R,,  Cermak J, Sanz G, Hellström-Lindberg E, Langemeijer S, Holm MS, Madry K, Tatic A, Almeida AM, Savic A,,  Mandac Rogulj I, Germing U, Smith A.

van Zeventer et al. 2021.

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Isabelle A. van Zeventer,  Aniek O. de Graaf,  Melanie M. van der Klauw,  Edo Vellenga,  Bert A. van der Reijden,  Jan Jacob Schuringa,  Arjan Diepstra,  Luca Malcovati,  Joop H. Jansen,  Gerwin Huls.

Blood Advances
Volume: 5, Issue: 17, Pages: 3266-3278.

Oster et al. 2021.

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS

Howard S. Oster,  Simon Crouch,  Alexandra Smith,  Ge Yu,  Bander Abu Shrkihe,  Shoham Baruch,  Albert Kolomansky,  Jonathan Ben-Ezra,  Shachar Naor,  Pierre Fenaux,  Argiris Symeonidis,  Reinhard Stauder,  Jaroslav Cermak,  Guillermo Sanz,  Eva Hellström-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Mette Skov Holm,  Krzysztof Madry,  Agnes Guerci-Bresler,  Dominic Culligan,  Laurence Sanhes,  Juliet Mills,  Ioannis Kotsianidis,  Corine van Marrewijk,  David Bowen,  Theo de Witte,  Moshe Mittelman.

Blood Advances
Volume: 5, Issue: 16, Pages: 3066-3075.

Sandmann et al. 2021.

CooPer plots – the next level of UpSet plots

Sarah Sandmann,  Martin Dugas,  Julian Varghese.

F1000Research
Volume: 10.

Hoeks et al. 2021.

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Marlijn Hoeks,  Tim Bagguley,  Corine van Marrewijk,  Alex Smith,  David Bowen,  Dominic Culligan,  Seye Kolade,  Argiris Symeonidis,  Hege Garelius,  Michail Spanoudakis,  Saskia Langemeijer,  Rian Roelofs,  Erwin Wiegerinck,  Aurelia Tatic,  Sally Killick,  Panagiotis Panagiotidis,  Oana Stanca,  Eva Hellström-Lindberg,  Jaroslav Cermak,  Melanie van der Klauw,  Hanneke Wouters,  Marian van Kraaij,  Nicole Blijlevens,  Dorine W. Swinkels,  Theo de Witte.

Leukemia
Volume: 35, Issue: 6, Pages: 1745-1750.

van Zeventer et al. 2021.

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged =80 years

Isabelle A. van Zeventer,  Jonas B. Salzbrunn,  Aniek O. de Graaf,  Bert A. van der Reijden,  H. Marike Boezen,  Judith M. Vonk,  Pim van der Harst,  Jan Jacob Schuringa,  Joop H. Jansen,  Gerwin Huls.

Blood Advances
Volume: 5, Issue: 8, Pages: 2115-2122.

Sandmann et al. 2021.

Multicenter Next-Generation Sequencing Studies between Theory and Practice: Harmonization of Data Analysis Using Real-World Myelodysplastic Syndrome Data

Sarah Sandmann,  Aniek O. de Graaf,  Magnus Tobiasson,  Olivier Kosmider,  María Abáigar,  Emmanuelle Clappier,  Anna Gallì,  Bert A. van der Reijden,  Luca Malcovati,  Pierre Fenaux,  María Díez-Campelo,  Michaela Fontenay,  Eva Hellström-Lindberg,  Joop H. Jansen,  Martin Dugas.

The Journal of Molecular Diagnostics
Volume: 23, Issue: 3, Pages: 347-357.

Banck et al. 2021.

Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML

Henrik Banck,  Martin Dugas,  Carsten Müller-Tidow,  Sarah Sandmann.

Cancer Genomics & Proteomics
Volume: 18, Issue: 2, Pages: 157-166.

Duetz et al. 2021.

Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype

Carolien Duetz,  Theresia M. Westers,  Florentien E. M. in ’t Hout,  Eline M. P. Cremers,  Canan Alhan,  Bianca Venniker-Punt,  Heleen A. Visser-Wisselaar,  Dana A. Chitu,  Aniek O. de Graaf,  Linda Smit,  Joop H. Jansen,  Arjan A. van de Loosdrecht.

British Journal of Haematology
Volume: 193, Issue: 4, Pages: 798-803.

Duetz et al. 2021.

Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  Yvan Saeys,  Arjan A. van de Loosdrecht.

Cytometry Part A
Volume: 99, Issue: 8, Pages: 814-824.

Wouters et al. 2021.

Association Between Peripheral Blood Cell Count Abnormalities and Health-Related Quality of Life in the General Population

Hanneke J. C. M. Wouters,  Isabelle A. van Zeventer,  Melanie M. van der Klauw,  Bruce H. R. Wolffenbuttel,  Gerwin Huls.

HemaSphere
Volume: 5, Issue: 1, Pages: e503.

Stojkov et al. 2020.

Longitudinal Study on Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Marjan Arvandi,  Karin A Koinig,  M Schomaker,  Pierre Fenaux,  David Bowen,  Argiris Symeonidis,  Moshe Mittelman,  Jaroslav Cermak,  Guillermo Sanz,  Eva Hellstrom Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Mette Holm,  Krzysztof Madry,  A Guerci-Bresler,  Dominic Culligan,  Ioannis Kotsianidis,  Laurence Sanhes,  Juliet Mills,  Sibylle Puntscher,  D Schmid,  Corine Van Marrewijk,  Alexandra Smith,  T. M. de Witte,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 136, Issue: S1, Pages: #1279.

Sandmann et al. 2020.

CopyDetective: Detection threshold–aware copy number variant calling in whole-exome sequencing data

Sarah Sandmann,  Marius Wöste,  Aniek O de Graaf,  Birgit Burkhardt,  Joop H Jansen,  Martin Dugas.

GigaScience
Volume: 9, Issue: 11, Pages: giaa118.

Malcovati et al. 2020.

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Luca Malcovati,  Simon Crouch,  Aniek O. De Graaf,  Sarah Sandmann,  Magnus Tobiasson,  Olivier Kosmider,  Bert A. van der Reijden,  Daniel Painter,  Arjan A. Van de Loosdrecht,  Argiris Symeonidis,  Jaroslav Cermak,  Emmanuelle Clappier,  Claude Preudhomme,  Reinhard Stauder,  Moshe Mittelman,  Ulrich Germing,  David Bowen,  Pierre Fenaux,  Corine Van Marrewijk,  Alexandra Smith,  Martin Dugas,  Eva Hellstrom Lindberg,  Theo M de Witte,  Michaela Fontenay,  Joop Jansen.

Blood
Volume: 136, Issue: S1.

Witte et al. 2020.

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

Theo de Witte,  Luca Malcovati,  Pierre Fenaux,  David Bowen,  Argiris Symeonidis,  Moshe Mittelman,  Reinhard Stauder,  Guillermo Sanz,  Jaroslav Cermák,  Saskia Langemeijer,  Eva Hellström-Lindberg,  Ulrich Germing,  Mette Skov Holm,  Krzysztof Madry,  Aurelia Tatic,  António Medina Almeida,  Aleksandar Savic,  Inga Mandac Rogulj,  Raphael Itzykson,  Marlijn Hoeks,  Hege Gravdahl Garelius,  Dominic Culligan,  Ioannis Kotsianidis,  Lionel Ades,  Arjan A. Van de Loosdrecht,  Corine van Marrewijk,  Ge Yu,  Simon Crouch,  Alex Smith.

Haematologica
Volume: 105, Issue: 11, Pages: 2516-2523.

Stojkov et al. 2020.

Guideline-based indicators for adult patients with myelodysplastic syndromes

Kristina Stojkov,  Tobias Silzle,  Georg Stussi,  David Schwappach,  Juerg Bernhard,  David Bowen,  Jaroslav Cermák,  Avinash G. Dinmohamed,  Corien Eeltink,  Sabrina Eggmann,  Pierre Fenaux,  Ulrich Germing,  Manuel Haschke,  Eva Hellstrom-Lindberg,  Monika Heger,  Arjan A. van de Loosdrecht,  Jakob Passweg,  Michael Pfeilstöcker,  Uwe Platzbecker,  Luca Malcovati,  António Medina de Almeida,  Moshe Mittelman,  Christine Morgenthaler,  David P. Steensma,  Valeria Santini,  Reinhard Stauder,  Argiris Symeonidis,  Sämi Schär,  Charlotte Maddox,  Theo de Witte,  Julia Bohlius,  Nicolas Bonadies,  on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK).

Blood Advances
Volume: 4, Issue: 16, Pages: 4029-4044.

Tekath and Dugas 2020.

DTUrtle – Differential transcript usage analysis for bulk and single-cell data

Tobias Tekath,  Martin Dugas.

F1000Research
Volume: 9, Issue: 861.

Hellström-Lindberg et al. 2020.

Myelodysplastic syndromes: moving towards personalized management

Eva Hellström-Lindberg,  Magnus Tobiasson,  Peter Greenberg.

Haematologica
Volume: 105, Issue: 7, Pages: 1765-1779.

van Zeventer et al. 2020.

Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals

Isabelle A. van Zeventer,  Aniek O. de Graaf,  Hanneke J. C. M. Wouters,  Bert A. van der Reijden,  Melanie M. van der Klauw,  Theo de Witte,  Marianne A. Jonker,  Luca Malcovati,  Joop H. Jansen,  Gerwin Huls.

Blood
Volume: 135, Issue: 14, Pages: 1161-1170.

Swart et al. 2020.

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

Louise de Swart,  Simon Crouch,  Marlijn Hoeks,  Alex Smith,  Saskia Langemeijer,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermâk,  Eva Hellström-Lindberg,  Reinhard Stauder,  Guillermo Sanz,  Moshe Mittelman,  Mette Skov Holm,  Luca Malcovati,  Krzysztof Madry,  Ulrich Germing,  Aurelia Tatic,  Aleksandar Savic,  Antonio Medina Almeida,  Njetocka Gredelj-Simec,  Agnes Guerci-Bresler,  Odile Beyne-Rauzy,  Dominic Culligan,  Ioannis Kotsianidis,  Raphael Itzykson,  Corine van Marrewijk,  Nicole Blijlevens,  David Bowen,  Theo de Witte,  on behalf of the EUMDS Registry Participants.

Haematologica
Volume: 105, Issue: 3, Pages: 632-639.

Hoeks et al. 2020.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Marlijn Hoeks,  Ge Yu,  Saskia Langemeijer,  Simon Crouch,  Louise de Swart,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermák,  Eva Hellström-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Luca Malcovati,  Aurelia Tatic,  Antonio Medina Almeida,  Ulrich Germing,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Dominic Culligan,  Raphael Itzykson,  Agnes Guerci-Bresler,  Borhane Slama,  Jackie Droste,  Corine van Marrewijk,  Arjan van de Loosdrecht,  Nicole Blijlevens,  Marian van Kraaij,  David Bowen,  Theo de Witte,  Alex Smith,  on behalf of the EUMDS Registry Participants.

Haematologica
Volume: 105, Issue: 3, Pages: 640-651.

Duetz et al. 2020.

Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?

Carolien Duetz,  Costa Bachas,  Theresia M. Westers,  Arjan A. van de Loosdrecht.

Current Opinion in Oncology
Volume: 32, Issue: 2, Pages: 162–169.

Wünsch et al. 2020.

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Christian Wünsch,  Henrik Banck,  Carsten Müller-Tidow,  Martin Dugas.

BMC Medical Genomics
Volume: 13, Issue: 1, Pages: 17.

Stojkov et al. 2020.

Delphi-Survey-Based Development of Core Patient-Reported Outcomes in Myelodysplastic Syndromes

I. Stojkov,  A Conrads-Frank,  U Rochau,  KA Koinig,  M Arvandi,  S Puntscher,  C van Marrewijk,  P Fenaux,  T de Witte,  F Efficace,  U Siebert,  R Stauder.

Stojkov et al. 2020.

Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

I. Stojkov,  A Conrads-Frank,  U Rochau,  M Arvandi,  KA Koinig,  M Schomaker,  S Puntscher,  D Schmid,  C van Marrewijk,  A. Smith,  T de Witte,  F Efficace,  R Stauder,  U Siebert.

Van de Loosdrecht 2020.

Diagnose en prognose van MDS

A. A. Van de Loosdrecht.

Sandmann et al. 2020.

Analyzing coverage in smMIPs data

S Sandmann,  AO de Graaf,  JH Jansen,  M Dugas.

van Zeventer 2020.

Mutatiespectrum en dynamiek van klonale hematopoése bij ouderen met anemie

Isabelle A. van Zeventer.

Rochau et al. 2020.

Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group

Ursula Rochau,  Igor Stojkov,  Annette Conrads-Frank,  Helena H. Borba,  Karin A. Koinig,  Marjan Arvandi,  Corine van Marrewijk,  Hege Garelius,  Ulrich Germing,  Argiris Symeonidis,  Guillermo F. Sanz,  Pierre Fenaux,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

British Journal of Haematology
Volume: 191, Issue: 3, Pages: 405-417.

Stojkov et al. 2020.

Determinants of Health-Related Quality of Life in Patients with Myelodysplastic Syndromes

I. Stojkov,  A Conrads-Frank,  U Rochau,  M Arvandi,  KA Koinig,  M Schomaker,  S Puntscher,  D Schmid,  C van Marrewijk,  A. Smith,  T de Witte,  F Efficace,  R Stauder,  U Siebert.

Sandmann and Dugas 2019.

How to “appreci8” Variant Calling in NGS Data

Sarah Sandmann,  Martin Dugas.

F1000Research
Volume: 8.

Stojkov et al. 2019.

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

K Stojkov,  T Silzle,  G Stussi,  D Schwappach,  J Bernhard,  D Bowen,  J Cermák,  A Dinmohamed,  C Eeltink,  S Eggmann,  P Fenaux,  U Germing,  M Haschke,  E Hellstrom-Lindberg,  M Heger,  AA van de Loosdrecht,  J Passweg,  M Pfeilstöcker,  U Platzbecker,  L Malcovati,  AM Almeida,  M Mittelman,  C Morgenthaler,  D Steensma,  V Santini,  R Stauder,  A Symeonidis,  S Schaer,  C, Maddox,  T de Witte,  J Bohlius,  N Bonadies,  Swiss Group of Clinical Cancer Research (SAKK).

Blood
Volume: 134.

Tekath and Dugas 2019.

DTUrtle – an easily accessible Differential Transcript Usage analysis pipeline

Tobias Tekath,  Martin Dugas.

F1000Research
Volume: 8.

Sandmann and Dugas 2019.

appreci8R: an R package for calling variants the "appreci8"-way</p>

Sarah Sandmann,  Martin Dugas.

F1000Research
Volume: 8.

Duetz et al. 2019.

Artificial intelligence for flow cytometry data analysis in suspected-MDS enables an accurate, objective and fast diagnosis

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  Yvan Saeys,  A. A. Van de Loosdrecht.

De Swart 2019.

Patiënten met laagrisico-MDS: met het oog op ijzergerelateerde problemat¡ek

L. De Swart.

Medidact - Hematlogie
Volume: 4 Augustus 2019, Issue: 4.

Wünsch and Dugas 2019.

AMLVaran: Improvements in user-friendlyness of a human NGS variant assessment system</p>

Christian Wünsch,  Martin Dugas.

F1000Research
Volume: 8.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.


Pages: S838.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes. S838

Marlijn Hoeks,  Timothy Bagguley,  R. Roelofs,  L. Swart,  David Bowen,  Argiris Symeonidis,  Corine van Marrewijk,  E. Hellstrom-Lindberg,  A. Tatic,  S. Langemeijer,  D. Culligan,  Mac Macheta,  H. Garelius,  M. Spanoudakis,  S. Killick,  P. Panagiotidis,  Stanca Ciocan,  J. Mills,  B. Pottinger,  T. Witte.


Volume: 3, Pages: 373.

Hoeks et al. 2019.

Transfusie-afhankelijkheid is geassocieerd met de aanwezigheid van toxische ijzersoorten en slechtere overleving bij patiënten met een laag-risico myelodysplastisch syndroom

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

Goede and Stauder 2019.

Multidisciplinary care in the hematology clinic: Implementation of geriatric oncology

Valentin Goede,  Reinhard Stauder.

Journal of Geriatric Oncology
Volume: 10, Issue: 3, Pages: 497-503.

Platzbecker et al. 2019.

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

U. Platzbecker,  P. Fenaux,  L. Adès,  A. Giagounidis,  V. Santini,  A. A. van de Loosdrecht,  D. Bowen,  T. de Witte,  G. Garcia-Manero,  E. Hellström-Lindberg,  U. Germing,  R. Stauder,  L. Malcovati,  Mikkael A. Sekeres,  David P. Steensma,  S. Gloaguen.

Blood
Volume: 133, Issue: 10, Pages: 1020-1030.

Wouters et al. 2019.

Association of anemia with health-related quality of life and survival: a large population-based cohort study

Hanneke J. C. M. Wouters,  Melanie M. van der Klauw,  Theo de Witte,  Reinhard Stauder,  Dorine W. Swinkels,  Bruce H. R. Wolffenbuttel,  Gerwin Huls.

Haematologica
Volume: 104, Issue: 3, Pages: 468-476.

Duetz et al. 2019.

Computational flow cytometry: a novel diagnostic tool in myelodysplastic syndromes

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  A. A. Van de Loosdrecht.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

HemaSphere
Volume: 3 (S1), Issue: 373.

Rochau et al. 2019.

Consensus on a Core Outcome Set for Myelodysplastic syndromes

U. Rochau,  I. Stojkov,  A. Conrads-Frank,  H. Borba,  K. Koining,  M. Arvandi,  C. Van Marrewijk,  H. Garelius,  U. Germing,  A. Symeonidis,  G. Sanz,  P. Fenaux,  T. De Witte,  F. Efficace,  U. Siebert,  R. Stauder.

Leukemia Research
Volume: 135.

Oster et al. 2019.

A Web Application Could Help in MDS Diagnosis and Obviate the Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  B Shoham,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Leukemia Research
Volume: 144.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.


Volume: 114, Pages: P-522.

Duetz et al. 2019.

Artificial intelligence improves flow cytometry in myelodysplastic syndromes

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  Yvan Saeys,  Arjan A. Van de Loosdrecht.

de Witte et al. 2019.

New prognostic indicators in MDS identified during the first 10 years of the EUropean LeukemiaNet MDS (EUMDS) Registry

T de Witte,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Tatic,  AM Almeida,  A Savic,  N Gredelj Šimec,  R Itzykson,  D Culligan,  I Kotsianidis,  L Ades,  AA van de Loosdrecht,  C van Marrewijk,  G Yu,  S Crouch,  L Malcovati,  A Smith.

Leukemia Research
Volume: 90.

Oster et al. 2019.

A Web Application Could Help Diagnose or Exclude MDS, Providing a Noninvasive Alternative to Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  J Ben-Ezra,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Robin and De Witte 2019.

Myelodysplastic Syndromes

Marie Robin,  T. De Witte.

Sandmann et al. 2018.

appreci8: a pipeline for precise variant calling integrating 8 tools

Sarah Sandmann,  Mohsen Karimi,  Aniek O. de Graaf,  Christian Rohde,  Stefanie Göllner,  Julian Varghese,  Jan Ernsting,  Gunilla Walldin,  Bert A. van der Reijden,  Carsten Müller-Tidow,  Luca Malcovati,  Eva Hellström-Lindberg,  Joop H. Jansen,  Martin Dugas.

Bioinformatics (Oxford, England)
Volume: 34, Issue: 24, Pages: 4205-4212.

Patton et al. 2018.

Identifying Multinational Cost Data: A Methodological Review and Case Study

Thomas Patton,  CM Hung,  M Henriksson,  M Huic,  AP Marques,  S Puntscher,  D Vukicevic,  M Ruggeri,  A Manca.

Oster et al. 2018.

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

HS Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  S Baruch,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermak,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Blood
Volume: 132.

Stojkov et al. 2018.

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A Koinig,  Helena Borba,  Marjan Arvandi,  Pierre Fenaux,  Argiris Symeonidis,  David Bowen,  Moshe Mittelman,  Corine van Marrewijk,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 132, Issue: Supplement 1, Pages: 2295.

Madry et al. 2018.

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

K Madry,  G Yu,  K Lis,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  S Couch,  T de Witte,  A Smith.

Blood
Volume: 132.

Stauder et al. 2018.

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

R. Stauder,  G. Yu,  K. A. Koinig,  D. Culligan,  P. Fenaux,  J. Cermak,  A. Symeonidis,  T. Bernal,  E. Hell-Strom-Lindberg,  M. Mittelman,  S. Langemeijer,  M. S. Holm,  J. Mills,  A. Guerci-Bresler,  C. van Marrewijk,  H. Garelius,  F. Efficace,  A. Smith,  D. Bowen,  T. M. de Witte.

Blood
Volume: 132.

Hoeks et al. 2018.

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellström-Lindberg,  A Tatic,  S Langemeijer,  DJ Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  DW Swinkels,  TM de Witte.

Blood
Volume: 132, Issue: S1.

Stojkov et al. 2018.

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A. Koinig,  Helena Borba,  Marjan Arvandi,  Pierre Fenaux,  Argiris Symeonidis,  David Bowen,  Moshe Mittelman,  Corine van Marrewijk,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 132, Issue: Supplement 1, Pages: 2295-2295.

Stojkov et al. 2018.

Developing a Core Outcome Set for Myelodysplastic Syndromes - an International Delphi Survey

Igor Stojkov,  Ursula Rochau,  Conrads-Frank Annette,  Karin Koinig,  Marjan Arvandi,  Argiris Symeonidis,  Sanz Guillermo,  Pierre Fenaux,  David Bowen,  Moshe Mittelmann,  Hege Garelius,  Ulrich Germing,  Corine van Marrewijk,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Alex Smith,  Theo de Witte,  Fabio Efficace,  Reinhard Stauder,  Uwe Siebert.


Volume: PS4-31, Pages: PS4-31.

Itzykson et al. 2018.

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Raphael Itzykson,  Simon Crouch,  Erica Travaglino,  Alex Smith,  Argiris Symeonidis,  Eva Hellström-Lindberg,  Guillermo Sanz,  Jaroslav Cermák,  Reinhard Stauder,  Chiara Elena,  Ulrich Germing,  Moshe Mittelman,  Saskia Langemeijer,  Krzysztof Madry,  Aurelia Tatic,  Mette Skov Holm,  Antonio Medina Almeida,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Elisa Luño,  Dominic Culligan,  Agnes Guerci-Bresler,  Luca Malcovati,  Corine van Marrewijk,  David Bowen,  Theo de Witte,  Pierre Fenaux,  on behalf of the European MDS Registry members.

Blood Advances
Volume: 2, Issue: 16, Pages: 2079-2089.

Stahl et al. 2018.

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Maximilian Stahl,  Michelle DeVeaux,  Theo de Witte,  Judith Neukirchen,  Mikkael A. Sekeres,  Andrew M. Brunner,  Gail J. Roboz,  David P. Steensma,  Vijaya R. Bhatt,  Uwe Platzbecker,  Thomas Cluzeau,  Pedro H. Prata,  Raphaël Itzykson,  Pierre Fenaux,  Amir T. Fathi,  Alexandra Smith,  Ulrich Germing,  Ellen K. Ritchie,  Vivek Verma,  Aziz Nazha,  Jaroslaw P. Maciejewski,  Nikolai A. Podoltsev,  Thomas Prebet,  Valeria Santini,  Steven D. Gore,  Rami S. Komrokji,  Amer M. Zeidan.

Blood Advances
Volume: 2, Issue: 14, Pages: 1765-1772.

Brix et al. 2018.

ODM Data Analysis—A tool for the automatic validation, monitoring and generation of generic descriptive statistics of patient data

Tobias Johannes Brix,  Philipp Bruland,  Saad Sarfraz,  Jan Ernsting,  Philipp Neuhaus,  Michael Storck,  Justin Doods,  Sonja Ständer,  Martin Dugas.

PLOS ONE
Volume: 13, Issue: 6, Pages: e0199242.

Stojkov et al. 2018.

DEVELOPING A CORE OUTCOME SET FOR MYELODYSPLASTIC SYNDROMES – THE MDS-RIGHT HEALTH PROFESSIONAL DELPHI SURVEY

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin Koinig,  Marjan Arvandi,  Argiris Symeonidis,  Sanz Guillermo,  Pierre Fenaux,  David Bowen,  Moshe Mittelman,  Hege Garelius,  Ulrich Germing,  Corine Van Marrewijk,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Alexandra Smith,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.


Pages: PB2100.

Stojkov et al. 2018.

Systematic Overview of Patient-Reported Outcomes for Myelodysplastic Syndromes

Igor Stojkov,  Ursula Rochau,  Conrads-Frank Annette,  Helena Borba,  Karin Koinig,  Marjan Arvandi,  Fabio Efficace,  Reinhard Stauder,  Uwe Siebert.

Wöste and Dugas 2018.

VIPER: a web application for rapid expert review of variant calls

Marius Wöste,  Martin Dugas.

Bioinformatics
Volume: 34, Issue: 11, Pages: 1928-1929.

Stauder et al. 2018.

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Reinhard Stauder,  Ge Yu,  Karin A. Koinig,  Tim Bagguley,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Jaroslav Cermak,  Moshe Mittelman,  Eva Hellström-Lindberg,  Saskia Langemeijer,  Mette Skov Holm,  Krzysztof Madry,  Luca Malcovati,  Aurelia Tatic,  Ulrich Germing,  Aleksandar Savic,  Corine van Marrewijk,  Agnès Guerci-Bresler,  Elisa Luño,  Jackie Droste,  Fabio Efficace,  Alex Smith,  David Bowen,  Theo de Witte.

Leukemia
Volume: 32, Issue: 6, Pages: 1380-1392.

Garelius 2018.

Registry studies on myelodysplastic syndrome and secondary acute myeloid leukemia

H. Garelius.

Berger et al. 2018.

Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT

Gerbrig Berger,  Leonie I. Kroeze,  Theresia N. Koorenhof-Scheele,  Aniek O. de Graaf,  Kenichi Yoshida,  Hiroo Ueno,  Yuichi Shiraishi,  Satoru Miyano,  Eva van den Berg,  Hein Schepers,  Bert A. van der Reijden,  Seishi Ogawa,  Edo Vellenga,  Joop H. Jansen.

Blood
Volume: 131, Issue: 16, Pages: 1846-1857.

de Swart et al. 2018.

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS

Louise de Swart,  Alex Smith,  Detlef Haase,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Guillermo Sanz,  Reinhard Stauder,  Moshe Mittelman,  Eva Hellström-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Mette Skov-Holm,  Krzysztof Madry,  Ulrich Germing,  Antonio Medina Almeida,  Aurelia Tatic,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Corine van Marrewijk,  Agnes Guerci-Bresler,  Laurence Sanhes,  Elisa Luño,  Dominic Culligan,  Odile Beyne-Rauzy,  Sonja Burgstaller,  Nicole Blijlevens,  David Bowen,  Theo de Witte.

Leukemia Research
Volume: 67, Pages: 21-26.

van Spronsen 2018.

Immuunfenotype als voorspeller voor pregressie bij MDS

Margot F. van Spronsen.

NTVH - Nederlands Tijdschrift voor Hematologie
Volume: DHC Special, Issue: 2018.

Jansen 2018.

Moleculaire Diagnostiek

Joop Jansen.

NTVH - Nederlands Tijdschrift voor Hematologie
Volume: DHC Special 2018, Pages: 70-71.

Wouters 2018.

Anemie en kwaliteit van leven

Hanneke Wouters.

NTVH - Nederlands Tijdschrift voor Hematologie
Volume: DHC Special 2018.

Efficace et al. 2018.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes: Patient-Reported Outcomes and Survival

Fabio Efficace,  Francesco Cottone,  Gregory Abel,  Pasquale Niscola,  Gianluca Gaidano,  Franck Bonnetain,  Amelie Anota,  Giovanni Caocci,  Angel Cronin,  Luana Fianchi,  Massimo Breccia,  Reinhard Stauder,  Uwe Platzbecker,  Giuseppe A. Palumbo,  Mario Luppi,  Rosangela Invernizzi,  Micaela Bergamaschi,  Lorenza Borin,  Anna Angela Di Tucci,  Huiyong Zhang,  Mirjam Sprangers,  Marco Vignetti,  Franco Mandelli.

Cancer
Volume: 124, Issue: 6, Pages: 1251-1259.

Valent et al. 2018.

Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform

Peter Valent,  Reinhard Stauder,  Igor Theurl,  Klaus Geissler,  Thamer Sliwa,  Wolfgang R. Sperr,  Peter Bettelheim,  Heinz Sill,  Michael Pfeilstöcker.

Expert Review of Hematology
Volume: 11, Issue: 2, Pages: 109-116.

Swart et al. 2018.

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Louise de Swart,  Chloé Reiniers,  Timothy Bagguley,  Corine van Marrewijk,  David Bowen,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin Huls,  Jaroslav Cermak,  Arjan A. van de Loosdrecht,  Hege Garelius,  Dominic Culligan,  Mac Macheta,  Michail Spanoudakis,  Panagiotis Panagiotidis,  Marta Krejci,  Nicole Blijlevens,  Saskia Langemeijer,  Jackie Droste,  Dorine W. Swinkels,  Alex Smith,  Theo de Witte.

Haematologica
Volume: 103, Issue: 1, Pages: 69-79.

Duetz et al. 2018.

Computational flow cytometry: a diagnostic tool in MDS

Carolien Duetz,  Sofie Van Gassen,  Theresia M. Westers,  Margot F. van Spronsen,  Costa Bachas,  A. A. Van de Loosdrecht.

Hoeks, M. et al. 2018.

Impact van behandeling met ijzerchelatietherapie op patiënten met een laag-risico myelodysplastisch syndroom die deelnemen aan de Europese MDS registratie

Hoeks, M.,  G. Yu,  S. Langemeijer,  S. Crouch,  L. de Swart,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  G. Sanz,  R. Stauder,  M. Skov Holm,  M. Mittelman,  K. Madry,  L. Malcovati,  A. Tatic,  A. M. Almeida,  U. Germing,  A. Savic,  N. Gredelj Šimec,  D. Culligan,  R. Itzykson,  A. Guerci-Bresler,  B. Slama,  C. Van Marrewijk,  J. Droste,  M. van Kraaij,  D. Bowen,  T. M. de Witte,  A. Smith.

de Swart et al. 2018.

Impact of Red Blood Cell Transfusion Rate, Adjusted by Therapeutic interventions, on Progression-Free Survival in Lower-Risk MDS Patients within the European LeukemiaNet MDS Registry

L. de Swart,   Hoeks, M.,  S. Crouch,  A. Smith,  S. Langemeijer,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  R. Stauder,  G. Sanz,  M. Mittelman,  M. S. Holm,  L. Malcovati,  K. Madry,  U. Germing,  A. Savic,  A. M. Almeida,  A. Guerci-Bresler,  R. Itzykson,  O. Beyne-Rauzy,  D. Culligan,  C. van Marrewijk,  N. M. A. Blijlevens,  D. Bowen,  T. M. de Witte.


Volume: 215537, Pages: PS1233.

Langemeijer and Hoeks, M. 2018.

Ijzerchelatie bij laag-risico myelodysplsie

S. Langemeijer,   Hoeks, M..

NTvH 2018 April DHC special

Mkadmi 2018.

Assessing whether the number of metaphases analyzed in patient with low-risk myelodysplastic syndrome and normal karyotype expose any prognostic information

H. Mkadmi.

Symeonidis et al. 2017.

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS). a Study of the European LeukemiaNet-Based MDS (EUMDS) Registry

Argiris Symeonidis,  Ge Yu,  Alexandra Smith,  Pierre Fenaux,  Moshe Mittelman,  Reinhard Stauder,  Guillermo Sanz,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  K. Madry,  Skov Mette,  Mette Holm,  A. Tatic,  Antonio Almeida,  Alek-Sandar Savic,  Njetocka Gredelj,  David Bowen.

Oster et al. 2017.

Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

Howard Oster,  Bander Shrkihe,  Simon Crouch,  Alexandra Smith,  Ge Yu,  Gal Carmi,  Jona-Than Ben-Ezra,  Shachar Naor,  Pierre Fenaux,  Argiris Symeonidis,  Reinhard Stauder,  Jaroslav Cer-Mak,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Skov Mette,  Mette Holm,  Moshe Mittelman.

Verwimp-Hoeks et al. 2017.

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Marlijn Verwimp-Hoeks,  Ge Yu,  Saskia Langemeijer,  Simon Crouch,  L. Swart,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Mette Holm,  Moshe Mittelman,  K. Madry,  Luca Malcovati,  A. Tatic,  Antonio Almeida,  Ulrich Germing,  Aleksandar Savic,  Alex Smith.

Swart et al. 2017.

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

L. Swart,  Simon Crouch,  Marlijn Verwimp-Hoeks,  Alex Smith,  Saskia Langemeijer,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Reinhard Stauder,  Moshe Mittelman,  Guillermo Sanz,  Eva Hell-Strom-Lindberg,  Luca Malcovati,  Skov Mette,  Mette Holm,  Ulrich Germing,  K. Madry,  Antonio Almeida,  A. Tatic,  T Witte.

Itzykson et al. 2017.

A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European LeukemiaNet Lower-Risk MDS (EUMDS) Registry

Raphael Itzykson,  Simon Crouch,  Alex Smith,  Argiris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Moshe Mittelman,  Saskia Langemeijer,  K. Madry,  A. Tatic,  Skov Mette,  Mette Holm,  Antonio Almeida,  Aleksandar Savic,  Njetocka Gredelj,  Pierre Fenaux.

Valent et al. 2017.

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Peter Valent,  Attilio Orazi,  David P. Steensma,  Benjamin L. Ebert,  Detlef Haase,  Luca Malcovati,  Arjan A. van de Loosdrecht,  Torsten Haferlach,  Theresia M. Westers,  Denise A. Wells,  Aristoteles Giagounidis,  Michael Loken,  Alberto Orfao,  Michael Lübbert,  Arnold Ganser,  Wolf-Karsten Hofmann,  Kiyoyuki Ogata,  Julie Schanz,  Marie C. Béné,  Gregor Hoermann,  Wolfgang R. Sperr,  Karl Sotlar,  Peter Bettelheim,  Reinhard Stauder,  Michael Pfeilstöcker,  Hans-Peter Horny,  Ulrich Germing,  Peter Greenberg,  John M. Bennett.

Oncotarget
Volume: 8, Issue: 43, Pages: 73483-73500.

de Swart et al. 2017.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

Louise de Swart,  Alex Smith,  Marius MacKenzie,  Argiris Symeonidis,  Judith Neukirchen,  Dana Mikulenková,  Teresa Vallespí,  Gina Zini,  Malgorzata Paszkowska-Kowalewska,  Anton Kruger,  Leonie Saft,  Pierre Fenaux,  David Bowen,  Eva Hellström-Lindberg,  Jaroslav Cermák,  Reinhard Stauder,  Aurelia Tatic,  Mette Skov Holm,  Luca Malcovati,  Krzysztof Madry,  Jackie Droste,  Nicole Blijlevens,  Theo de Witte,  Ulrich Germing.

Annals of Hematology
Volume: 96, Issue: 7, Pages: 1105-1112.

da Silva-Coelho et al. 2017.

Clonal evolution in myelodysplastic syndromes

Pedro da Silva-Coelho,  Leonie I. Kroeze,  Kenichi Yoshida,  Theresia N. Koorenhof-Scheele,  Ruth Knops,  Louis T. van de Locht,  Aniek O. de Graaf,  Marion Massop,  Sarah Sandmann,  Martin Dugas,  Marian J. Stevens-Kroef,  Jaroslav Cermak,  Yuichi Shiraishi,  Kenichi Chiba,  Hiroko Tanaka,  Satoru Miyano,  Theo de Witte,  Nicole M. A. Blijlevens,  Petra Muus,  Gerwin Huls,  Bert A. van der Reijden,  Seishi Ogawa,  Joop H. Jansen.

Nature Communications
Volume: 8, Issue: 1, Pages: 15099.

Stauder et al. 2017.

22 - Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival

R. Stauder,  G. Yu,  K. Koinig,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellström-Lindberg,  S. Langemeijer,  M. Skov Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  F. Efficace,  A. Smith,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S12.

Itzykson et al. 2017.

19 - Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

R. Itzykson,  A. Smith,  P. Fenaux,  A. Symeonidis,  M. Mittelman,  R. Stauder,  G. Sanz,  J. Cermák,  E. Hellström-Lindberg,  L. Malcovati,  S. Langemeijer,  U. Germing,  K. Madry,  M. S. Holm,  A. Tatic,  A. M. Almeida,  A. Savic,  N. Gredelj Šimec,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S10-S11.

de Swart et al. 2017.

280 - Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  S. Crouch,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  S. Langemeijer,  M. Skov Holm,  M. Mittelman,  K. Madry,  A. Almeida,  A. Savic,  R. Itzykson,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S160-S161.

de Witte et al. 2017.

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Theo de Witte,  David Bowen,  Marie Robin,  Luca Malcovati,  Dietger Niederwieser,  Ibrahim Yakoub-Agha,  Ghulam J. Mufti,  Pierre Fenaux,  Guillermo Sanz,  Rodrigo Martino,  Emilio Paolo Alessandrino,  Francesco Onida,  Argiris Symeonidis,  Jakob Passweg,  Guido Kobbe,  Arnold Ganser,  Uwe Platzbecker,  Jürgen Finke,  Michel van Gelder,  Arjan A. van de Loosdrecht,  Per Ljungman,  Reinhard Stauder,  Liisa Volin,  H. Joachim Deeg,  Corey Cutler,  Wael Saber,  Richard Champlin,  Sergio Giralt,  Claudio Anasetti,  Nicolaus Kröger.

Blood
Volume: 129, Issue: 13, Pages: 1753-1762.

Sandmann et al. 2017.

BBCAnalyzer: a visual approach to facilitate variant calling

Sarah Sandmann,  Aniek O. de Graaf,  Martin Dugas.

BMC Bioinformatics
Volume: 18, Issue: 1, Pages: 133.

Sandmann et al. 2017.

Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data

Sarah Sandmann,  Aniek O. de Graaf,  Mohsen Karimi,  Bert A. van der Reijden,  Eva Hellström-Lindberg,  Joop H. Jansen,  Martin Dugas.

Scientific Reports
Volume: 7, Issue: 1, Pages: 43169.

Sandmann et al. 2017.

GLM-based optimization of NGS data analysis: A case study of Roche 454, Ion Torrent PGM and Illumina NextSeq sequencing data

Sarah Sandmann,  Aniek O. de Graaf,  Bert A. van der Reijden,  Joop H. Jansen,  Martin Dugas.

PLOS ONE
Volume: 12, Issue: 2, Pages: e0171983.

Garelius et al. 2017.

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome

H. K. G. Garelius,  W. T. Johnston,  A. G. Smith,  S. Park,  L. de Swart,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermák,  R. Stauder,  L. Malcovati,  M. Mittelman,  A. A. van de Loosdrecht,  C. J. van Marrewijk,  D. Bowen,  S. Crouch,  T. J. M. de Witte,  E. Hellström-Lindberg.

Journal of Internal Medicine
Volume: 281, Issue: 3, Pages: 284-299.

de Witte 2017.

MDS: de juiste zorg op het juiste moment - MDS is een complexe en relatief zeldzame ziekte, maar het aantal patiënten groeit. Het project MDS-RIGHT heeft tot doel de zorg voor MDS-patiënten te verbeteren. Op welke manier?

Theo M de Witte.

HEMATON magazine
Volume: 16.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European LeukemiaNet MDS (EUMDS) Registry

Saskia Langemeijer,  L. Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  W Thomas Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Holm,  Moshe Mittelman,  K. Madry,  A. Tatic,  Antonio Almeida,  Theo Witte.

Hoeks et al. 2016.

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks,  Saskia Langemeijer,  Louise De Swart,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Marian G. J. Van Kraaij,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic J. Culligan,  Marta Krejci,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 4327-4327.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Saskia Langemeijer,  Louise De Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  Tom Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 3186-3186.

Stauder et al. 2016.

Comparison of 1690 MDS Patients from the European Leukemianet Registry and Reference Populations - Evidence for a Significant Impairment in Qol in MDS and Definition of Predictors of Diminished Qol

R. Stauder,  G. Yu,  T. Bagguley,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellstrom-Lindberg,  S. Langemeijer,  M. S. Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  C. van Marrewijk,  A. Guerci-Bresler,  E. Luno,  J. Droste,  K. Koinig,  A. Smith,  D. Bowen,  T. de Witte.

Haematologica
Volume: 101, Pages: 16-17.

De Swart et al. 2015.

Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry

Louise De Swart,  Tom Johnston,  Alexandra Smith,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Gerwin Huls,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Medina Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 1677-1677.

De Swart et al. 2015.

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin Huls,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic Culligan,  Marta Krejci,  Corine van Marrewijk,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 2865-2865.

de Swart et al. 2015.

Prognostic Impact of Transfusion Intensity on Survival and Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  W. T. Johnston,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  G. Huls,  M. S. Holm,  M. Mittelman,  K. Madry,  A. Tatic,  A. M. Almeida,  A. Savic,  S. Park,  O. Beyne-Rouzy,  R. Itzykson,  J. Droste,  D. Bowen,  T. de Witte.


Volume: 39, Pages: S23-S24.

de Swart et al. 2015.

Transfusions and Presence of Ringsideroblasts Influence Hepcidin and NTBI Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) - a Report from the European Leukemianet MDS Registry

L. de Swart,  C. Reiniers,  T. Bagguley,  C. Van Marrewijk,  D. Bowen,  J. Cermak,  E. Hellström-Lindberg,  A. Tatic,  A. Symeonidis,  G. Huls,  P. Panagiotidis,  H. Garelius,  D. Culligan,  M. Krejci,  J. Droste,  A. Smith,  D. Swinkels,  T. de Witte.

Leukemia Research
Volume: 39, Pages: S106-S107.

Stauder et al. 2015.

Determinants of Health-Related Quality of Life in Elderly MDS-Patients - A study from the European LeukemiaNet MDS Registry

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. Skov Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  T. Johnston,  D. Bowen,  T. de Witte.

SIOG

Swart et al. 2015.

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

Louise de Swart,  Alex Smith,  Thomas W. Johnston,  Detlef Haase,  Jackie Droste,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Eva Hellström-Lindberg,  Jaroslav Cermák,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette S. Holm,  Antonio M. Almeida,  Krzysztof Madry,  Borhane Slama,  Agnes Guerci-Bresler,  Laurence Sanhes,  Odile Beyne-Rauzy,  Elisa Luño,  David Bowen,  Theo de Witte.

British Journal of Haematology
Volume: 170, Issue: 3, Pages: 372-383.

Stauder et al. 2015.

Impact of MDS on Health-Related Quality of Life: A Comparison of IPSS Low-and Int-1 Risk MDS Patients from the European Leukemianet MDS (EUMDS) Registry and European Reference Populations

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. S. Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  W. T. Johnston,  D. Bowen,  T. de Witte.

Haematologica
Volume: 100.

De Swart et al. 2014.

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin A. Huls,  Alex Smith,  Theo de Witte.

Blood
Volume: 124, Issue: 21, Pages: 3267-3267.

Reiger et al. 2014.

Assessment of quality of life – a comparison of a German reference population a cohort from an Innsbruck senior fair and MDS-patients

A. Reiger,  G. Kemmler,  V. Bach,  S. Burgstaller,  L. de Swart,  A. Smith,  D. Bowen,  P. Fenaux,  T. de Witte,  R. Stauder.

Frühjahrstagung

Swart et al. 2013.

Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Tom Johnston,  Detlef Haase,  Jackie Droste,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Eva Hellström-Lindberg,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Antonio Medina Almeida,  Krzysztof Madry,  Borhane Slama,  Agnès Guerci-Bresler,  Laurence Sanhes,  Odile Beyne-Rauzy,  Elisa Luño,  David Bowen,  Theo de Witte.

Blood
Volume: 122, Issue: 21, Pages: 2770-2770.

Garelius et al. 2013.

European distribution of usage and impact on outcome for treatment with erythropoietic stimulating agents within the EUMDS lower-risk registry programme

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. De Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov-Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A. M. Antonio Medina Almeida,  D. Bowen,  T. De Witte,  A. Smith,  E. Hellström-Lindberg.

Leukemia Research
Volume: 37, Pages: S21-S22.

Stauder et al. 2013.

A longitudinal observational study on the health-related quality of life in IPSS low-risk MDS - impact of time course and transfusion need

R. Stauder,  T. Jonston,  A. Smith,  P. Fenaux,  J. Droste,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  A. Guerci,  L. Sanhes,  B. Iama,  E. Luno,  D. Bowen,  T. de Witte.

Haematologica
Volume: 98, Pages: 81.

Garelius et al. 2013.

European pattern and impact of the use of erythropoietic agents (ESAs) in low and int-1 risk with propensity scoring techniques in observational longitudinal studies

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. de Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A Medina Almeida,  D. Bowen,  T. de Witte,  A. Smith,  E. Hellstrom-Lindberg.

Haematologica
Volume: 98, Pages: 87-88.

de Swart et al. 2012.

Early Mortality in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Krzysztof Madry,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 120, Issue: 21, Pages: 3830-3830.

Itzykson et al. 2012.

Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy From the European Leukemianet Low Risk MDS (EUMDS) Registry

Raphael Itzykson,  Alex Smith,  Theo M. de Witte,  Jackie Droste,  Reinhard Stauder,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Mette Skov-Holm,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen,  Pierre Fenaux.

Blood
Volume: 120, Issue: 21, Pages: 700-700.

de Swart et al. 2011.

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  David Bowen,  Guillermo Sanz,  Eva Hellström-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  Theo de Witte.

Blood
Volume: 118, Issue: 21, Pages: 2775-2775.

de Swart et al. 2011.

Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry

L. de Swart,  A. Smith,  P. Fenaux,  A. Symeonidis,  E. Hellström-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  R. Stauder,  J. Droste,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 35, Pages: S3.

Stauder et al. 2011.

Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival

R. Stauder,  A. Smith,  T. de Witte,  J. Proste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. Mac Kenzie,  O. Beyne-Rauzy,  L. Malcovati,  D. Bowen.

Leukemia Research
Volume: 35, Pages: S12.

Stauder et al. 2010.

Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on the First 683 Patients From the European LeukemiaNet Registry

Reinhard Stauder,  Alex Smith,  Theo de Witte,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen.

Blood
Volume: 116, Issue: 21, Pages: 3999-3999.

de Swart et al. 2010.

Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellström-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  Reinhard Stauder,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 2917-2917.

Bowen et al. 2010.

The Population-Based ‘real world’ of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients

David Bowen,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne-Rauzy,  Luca Malcovati,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 1867-1867.

Stauder et al. 2010.

Assessment of Health-Related Quality of Life at Diagnosis in an European Registry for Low Risk and Intermediate-1 Risk MDS: Report of the first 322 patients

R. Stauder,  A. Smith,  T. de Witte,  J. Droste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  M. MacKenzie,  O. Beyne-Rauzy,  D. Bowen.

Haematologica
Volume: 95, Pages: 131-132.

de Witte et al. 2009.

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

T. M. de Witte,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne Rauzy,  David T. Bowen.

Blood
Volume: 114, Issue: 22, Pages: 3811-3811.

Bowen et al. 2009.

European LeukemiaNet registry programme for low/INT1 IPSS score myelodysplastic syndromes

David Bowen,  Jacqueline Droste,  Alexandra Smith,  P. Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  E. Hellström-Lindberg,  J. Cermak,  Radu Gologan,  U. Germing,  Reinhard Stauder,  L. Malcovati.

Leukemia Research - LEUK RES
Volume: 33.

Stojkov et al.

CONSENSUS SET OF CORE PATIENT-REPORTED OUTCOMES FOR MYELODYSPLASTIC... by Igor Stojkov

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A Koinig,  Marjan Arvandi,  Sibylle Puntscher,  Corine van Marrewijk,  Pierre Fenaux,  Argiris Symeonidis,  Fatiha Chermat,  Hege Garelius,  David Bowen,  Moshe Mittelman,  Elvira Mora,  T. De Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.


Volume: EP817.

Garelius et al.

IMPACT OF ERYTHROPOIETIN STIMULATION AGENTS AND RED BLOOD CELL... by Dr. Hege Garelius

Hege Garelius,  Alex Smith,  Simon Appleton,  David Bowen,  Pierre Fenaux,  Argiris Symeonidis,  Moshe Mittelman,  Reinhard Stauder,  Jaroslav Cermak,  Guillermo Sanz,  Saskia Langemeijer,  Mette Skov Holm,  Raphael Itzykson,  Dominic Culligan,  Sonja Heibi,  Juliet Mills,  T. Bernal,  Ioannis Kotsianidis,  Lionel Ades,  Karin A Koinig,  Corine van Marrewijk,  Simon Crouch,  T. De Witte,  Eva Hellstrom Lindberg.

Stojkov et al.

ASSESSING THE DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN... by Igor Stojkov

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Marjan Arvandi,  Karin A Koinig,  M Schomaker,  Sibylle Puntscher,  D Schmid,  Corine van Marrewijk,  Alex Smith,  Theo de Witte,  Uwe Siebert,  Reinhard Stauder.

Wouters et al.

THE ANEMIA-INDEPENDENT EFFECT OF MYELODYSPLASTIC SYNDROMES ON... by Hanneke Wouters

Hanneke Wouters,  Annette Conrads-Frank,  Karin A Koinig,  Alex Smith,  Ge Yu,  Theo de Witte,  Bruce H. R. Wolffenbuttel,  Gerwin Huls,  Uwe Siebert,  Reinhard Stauder,  Melanie M. van der Klauw.